Erratum: Correction of Tables in the Article “Maternal Exposures to COVID-19 Vaccine and Adverse Birth Outcomes: National Population Study in Korea”(Vol. 40, Number 17, e63, DOI:10.3346/jkms.2025.40.e63)

To the Editor: The authors regret that there were errors in Tables. This notice corrects Tables 1-3. Content of correction: Table 1. Demographic and clinical characteristics of pregnant women with COVID-19 vaccination during pregnancy and their matched control, the Korea Disease Control and Prevention Agency-COVID19-National Health Insurance Service cohort data (Table Presented.) Values are presented as number(%). The Seoul capital area refers to Seoul, Incheon, and Gyeonggi Provinces located in northwestern South Korea. COVID-19 = coronavirus disease 2019, 1Q = 1st quartile, 2Q = 2nd quartile, 3Q = 3rd quartile, 4Q = 4th quartile, SARS-CoV-2 = severe acute respiratory syndrome coronavirus 2. ^aP values were from Mantel-Haenszel χ² test. Table 2. Incidence and adjusted ORs of preterm birth and congenital malformation in the pregnant women who received any coronavirus disease 2019 vaccines during pregnancy and in their 1:4 matched control (Table Presented.) OR = odds ratio, CI = confidence interval. ^aAdjusted for women’s age, residential area (Seoul capital area or not), employment, income, disability, month of conception, pre-pregnancy obesity and smoking, and SARS-CoV-2 infection prior to pregnancy. Table 3. Incidence and adjusted ORs of preterm birth and congenital malformation in the pregnant women who received the mRNA-1273 or the NVX-CoV2373 and their 1:4 matched controls received the BNT162b2 during pregnancy (Table Presented.) OR = odds ratio, CI = confidence interval. ^aAdjusted for women’s age, residential area (Seoul capital area or not), employment, income, disability, month of conception, pre-pregnancy obesity and smoking, and SARS-CoV-2 infection prior to pregnancy.